Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 5, 1998, Pages 636-644

  De Haard, Hans J W ^a,e   Kazemier, Bert ^a   Koolen, Marck J M ^a   Nijholt, Liekle J ^a   Meloen, Rob H ^b   Van Gemen, Bob ^a   Hoogenboom, Hennie R ^c   Arends, Jan Willem ^c,d  

^a Organon Teknika   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GAG PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY DETECTION; ANTIGEN RECOGNITION; ARTICLE; EPITOPE MAPPING; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOMODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS INHIBITION;

EID: 0032440408     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.5.636-644.1998     Document Type: Article

References (71)

1. Barbas, C. F., and D. R. Burton. 1996. Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol. 14:230-234.
2. Barbas, C. F., T. A. Collet, W. Amberg, P. Roben, J. M. Binley, D. Hoelstra, D. Cababa, T. M. Jones, A. Williamson, G. R. Pilkington, N. L. Haigwood, E. Cabezas, A. C. Satterhwait, I. Sanz, and D. R. Burton. 1993. Molecular profile of an antibody response to HIV-1 as probed by combinatorial librar-ies. J. Mol. Biol. 230:812-823.
3. Baumberger, C., S. Kinloch-de-Loes, S. Yerly, B. Hirschel, and L. Perrin. 1993. High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS 7(Suppl. 2):S59-S64.
4. Berman, M. Unpublished data.
5. Billich, A., F. Hammerschmid, P. Peichl, R. Wenger, G. Zenke, V. Quesniaux, and B. Rosenwirth. 1995. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. J. Virol. 69:2451-2461.
6. Boeke, J. D., P. Model, and N. D. Zinder. 1982. Effects of bacteriophage f1 gene III protein on the host cell membrane. Mol. Gen. Genet. 186:185-192.
7. Boni. J., M. Opravil, Z. Tomasik, M. Rothen, L. Bisset, P. J. Grob, R. Luthy, and J. Schupbach. 1997. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS 11:F47-F52.
8. Braaten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-3560.
9. Brookmeyer, R., and T. C. Quinn. 1995. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am. J. Epidemiol. 141:166-172.
10. Busch, M. P., L. L. Lee, G. A. Satten, D. R. Henrard, H. Farzadegan, K. E. Nelson, S. Read, R. Y. Dodd, and L. R. Petersen. 1995. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 35:91-97.
11. Casey, J. M., Y. Kim, P. R. Andersen, K. F. Watson, J. L. Fox, and S. G. Devare. 1985. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24. J. Virol. 55:417-423.
12. Caton, A. J., and H. Koprowski. 1990. Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor. Proc. Natl. Acad. Sci. USA 87:6450-6454.
13. Chen, S. Y., Y. Khouri, J. Bagley, and W. A. Marasco. 1994. Combined intra-and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. USA 91:5932-5936.
14. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
15. Clackson, T., H. R. Hoogenboom, A. D. Griffiths, and G. Winter. 1991. Making antibody fragments using phage display libraries. Nature 352:624-628.
16. de Haard, H. J. W. Unpublished data.
17. Devey, M. E., and M. W. Steward. 1988. The role of antibody affinity in the performance of solid phase assays, p. 135-153. In D. M. Kemeny and S. J. Challacombe (ed.). ELISA and other solid phase immunoassays. John Wiley & Sons Ltd., London, United Kingdom.
18. Ditzel, H. J., J. M. Binley, J. P. Moore, J. Sodroski, N. Sullivan, L. S. Sawyer, R. M. Hendry, W. P. Yang, C. F. Barbas, and D. R. Burton. 1995. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J. Immunol. 154:893-906.
19. Dower, W. J., J. F. Miller, and C. W. Ragsdale. 1988. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16:6127-6145.
20. Ehrlich, L. S., B. E. Agresta, and C. A. Carter. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883.
21. Fischl, M. A., D. D. Richman, N. Hansen, A. C. Collier, J. T. Carey, M. F. Para, W. D. Hardy, R. Dolin, W. G. Powderly, J. D. Allan et al. 1990. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann. Intern. Med. 112:727-737.
22. Food and Drug Administration Center for Biologies Evaluation and Research. 1995. Recommendations for donor screening with a licensed test for HIV-1 antigen. Food and Drug Administration. Rockville, Md.
23. Foote, J., and H. N. Eisen. 1495. Kinetic and affinity limits on antibodies produced during immune responses. Proc. Natl. Acad. Sci. USA 92:1254-1256.
24. Geysen, H. M., R. H. Meloen, and S. J. Barteling. 1984. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA 81:3998-4002.
25. Gherardi, E., and C. Milstein. 1992. Original and artificial antibodies. Nature 357:201-202.
26. Gitti, R. K., B. M. Lee. J. Walker, M. F. Summers, S. Yoo, and W. I. Sundquist. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235.
27. Glaser, R. W., and G. Hausdorf. 1996. Binding kinetics of an antibody against HIV p24 core protein measured with real-time biomolecular interaction analysis suggest a slow conformational change in antigen p24. J. Immunol. Methods. 189:1-14.
28. Graziosi, C., G. Pantaleo, E. Butini, J. F. Demarest, M. S. Saag, G. M. Shaw, and A. S. Fauci. 1993. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 90:6405-6409.
29. Griffiths, A. D., M. Malmqvist, J. D. Marks, J. M. Bye, M. J. Embleton, J. McCafferty, M. Baier, K. P. Holliger, B. D. Gorick, J. N. Hughes, H. R. Hoogenboom, and G. Winter. 1993. Human anti-sell antibodies with high specificity from phage display libraries. EMBO J. 12:725-734.
30. Hinkula, J., J. Rosen, V. A. Sundqvist, T. Stigbrand, and B. Wahren. 1990. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol. Immunol. 27:395-403.
31. Holliger, P., T. Prospero, and G. Winter. 1993. "Diabodies": small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA 90:6444-6448.
32. Hoogenboom, H. R. 1997. Designing and optimizing library selection strategies for generating high-affinity antibodies. Trends Biotechnol. 15:62-70.
33. Hoogenboom, H. R., A. D. Griffiths, K. S. Johnson, D. J. Chiswell, P. Hudson, and G. Winter. 1991. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19:4133-4137.
34. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
35. Huston, J. S., D. Levinson, H. M. Mudgett, M. S. Tai, J. Novotny, M. N. Margolies, R. J. Ridge, R. E. Bruccoleri, E. Haber, R. Crea, and H. Opperman. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:5879-5883.
36. Janvier, B., P. Archinard, B. Mandrand, A. Goudeau, and F. Barin. 1990. Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2. J. Virol. 64:4258-4263.
37. Janvier, B., A. Baillou, P. Archinard, M. Mounier, B. Mandrand, A. Goudeau, and F. Barin. 1991. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis. J. Clin. Microbiol. 29:488-492.
38. Kabat, E. A., T. T. Wu, H. M. Perry, K. S. Gottesman, and C. Foeller. 1991. Sequences of proteins of immunological interest, 5th ed. National Institutes of Health, Bethesda, Md.
39. Kazemier, B., H. de Haard, P. Boender, B. van Gemen, and H. R. Hoogenboom. 1996. Determination of active single chain antibody concentrations in crude periplasmic fractions. J. Immunol. Methods 194:201-209.
40. Kellogg, D. E., J. J. Sninsky, and S. Kowk. 1990. Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction. Anal. Biochem. 189:202-208.
41. Kortt, A. A., M. Lah, G. W. Oddie, C. L. Gruen, J. E. Burns, L. A. Pearce, J. L. Atwell, A. J. McCoy, G. J. Howlett, D. W. Metzger, R. G. Webster, and P. J. Hudson. 1997. Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng. 10:423-433.
42. Lew, A. M. 1984. The effect of epitope density and antibody affinity on the ELISA as analysed by monoclonal antibodies. J. Immunol. Methods 72:171-176.
43. Luban, J., K. L. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type I Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
44. Marks, J. D., A. D. Griffiths, M. Malmqvist, T. P. Clackson, J. M. Bye, and G. Winter. 1992. By-passing immunization: building high affinity human antibodies by chain shuffling. Bio/Technology 10:779-783.
45. Marks, J. D., H. R. Hoogenboom, T. P. Bonnert, J. McCafferty, A. D. Griffiths, and G. Winter. 1991. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581-597.
46. McGuinness, B. T., G. Walter, K. FitzGerald, P. Schuler, W. Mahoney, A. R. Duncan, and H. R. Hoogenboom. 1996. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nat. Biotechnol. 14:1149-1154.
47. Mhashilkar, A. M., J. Bagley, S. V. Chen, A. M. Szilvay, D. G. Helland, and W. A. Marasco. 1995. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14:1542-1551.
48. Momany, C., L. C. Kovari, A. J. Prongay, W. Keller, R. K. Gitti, B. M. Lee, A. E. Gorbalenya, L. Tong, J. McClure, L. S. Ehrlich, M. F. Summers, C. Carter, and M. G. Rossmann. 1996. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 3:763-770.
49. Nieba, L., A. Krebber, and A. Pluckthun. 1996. Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal. Biochem. 234:155-165.
50. Niedrig, M., J. Hinkula, H. P. Harthus, M. Broker, L. Hopp, G. Pauli, and B. Wahren. 1991. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types I and 2. J. Virol. 65:4529-4533.
51. Niedrig, M., J. Hinkula, W. Weigelt, J. L'Age-Stehr, G. Pauli, J. Rosen, and B. Wahren. 1989. Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides. J. Virol. 63:3525-3528.
52. Niedrig, M., J. P. Rabanus, J. L'Age Stehr, H. R. Gelderblom, and G. Pauli. 1988. Monoclonal antibodies directed against human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus. J. Gen. Virol. 69:2109-2114.
53. Pluckthun, A., and P. Pack. 1997. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology 3:83-105.
54. Popovic, M., P. S. Sarin, M. K. Robert-Gurroff, V. S. Kalyanaraman, D. Mann, J. Minowada, and R. C. Gallo. 1983. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 219:856-859.
55. Prickett, K. S., D. C. Amberg, and T. P. Hopp. 1989. A calcium-dependent antibody for identification and purification of recombinant proteins. Bio-Techniques 7:580-589.
56. Robert-Hebmann, V., S. Emiliani, F. Jean, M. Resnicoff, F. Traincard, and C. Devaux. 1992. Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV1)-gag p17 and p25 antigens. Mol. Immunol. 29:729-738.
57. Robert-Hebmann, V., S. Emiliani, M. Resnicoff, F. Jean, and C. Devaux. 1992. Subtyping of human immunodeficiency virus isolates with a panel of monoclonal antibodies: identification of conserved and divergent epitopes on p17 and p25 core proteins. Mol. Immunol. 29:1175-1183.
58. Schier, R., J. Bye, G. Apell, A. McCall, G. P. Adams, M. Malmqvist, L. M. Weiner, and J. D. Marks. 1996. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J. Mol. Biol. 255:28-43.
59. Schier, R., A. McCall, G. P. Adams, K. W. Marshall, H. Merritt, M. Yim, R. S. Crawford, L. M. Weiner, C. Marks, and J. D. Marks. 1996. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J. Mol. Biol. 263:551-567.
60. Skerra, A., and A. Pluckthun. 1991. Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines. Protein Eng. 4:971-979.
61. Spector, S. A., C. Kennedy, J. A. McCutchan, S. A. Bozzette, R. G. Straube, J. D. Connor, and D. D. Richman. 1989. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J. Infect. Dis. 159:822-828.
62. Steinkasserer, A., R. Harrison, A. Billich, F. Hammerschmid, G. Werner, B. Wolff, P. Peichl, G. Palfi, W. Schnitzel, E. Mlynar, et al. 1995. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activitv against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. J. Virol. 69:814-824.
63. Stevens, P. W., C. H. Francis, M. E. Jolley, and D. R. Bethell. 1993. Monoclonal antibodies to HIV-1 p24 core protein include pairs which exhibit synergistic binding. Mol. Immunol. 30:243-254.
64. van Gemen, B., T. Kievits, P. Nara, H. G. Huisman, S. Jurriaans, J. Goudsmit, and P. Lens. 1993. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS. 7(Suppl. 2):S107-S110.
65. Veronese, F. D., T. D. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1988. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J. Virol. 62:795-801.
66. Volberding, P. A., S. W. Lagakos, M. A. Koch, C. Pettinelli, M. W. Myers, D. K. Booth, H. H. J. Balfour, R. C. Reichman, J. A. Bartlett, M. S. Hirsch, et al. 1990. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N. Engl. J. Med. 322:941-949.
67. Von Sydow, M., H. Gaines, A. Sonnerborg, M. Forsgren, P. O. Pehrson, and O. Strannegard. 1988. Antigen detection in primary HIV infection. Br. Med. J. Clin. Res. 296:238-240.
68. Wehrly, K., and B. Chesebro. 1997. p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 12:288-293.
69. Winter, G., A. D. Griffiths, R. E. Hawkins, and H. R. Hoogenboom. 1994. Making antibody by phage display technology. Annu. Rev. Immunol. 12:433-455.
70. Winter, G., and C. Milstein. 1991. Man-made antibodies. Nature 349:293-299.
71. Zhao, Y., Y. Chen, M. Schutkowski, G. Fischer, and H. Ke. 1997. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 5:139-146.